Alembic Global Advisors is an independent equity research firm offering differentiated, experienced financial analysis on a variety of global industrial sectors. Our goal is to provide high quality, proprietary and actionable research into company, industry and broader macro trends on a truly global level.
Since its founding in 2009, Alembic has expanded from its core global chemical coverage to the aerospace & defense sector. Our analysts have been recognized by industry publications Institutional Investor, FT/Starmine and Extel.2 research analysts covering 35 companies across 3 industries (Chemicals and Aerospace & Defense). Our coverage list continues to grow as we remain focused on delivering our best-in-class research product.
Through our corporate access events we provide unique opportunities to meet with a select group of industry leaders, offering the chance to gain unique insights from people operating at the highest levels of their respective industries.
In addition to highly analytical deep dive research surrounding our specific equity coverage, we provide our macro view of each industry against the global backdrop of current events and how we see them shaping the future. We leverage our various areas of expertise to produce a collaborative cross-sector research product. This non-siloed approach allows us to maximize our areas of expertise, ultimately achieving a more dynamic and in-depth level of insight.
Not a client? Please contact Stephen Matthews – stephen.matthews@alembicglobal.com – to learn more about our research subscription offerings.
Access is limited to Alembic Global Advisors clients.
Key Points We attended a small-group factory tour at WWD’s Rock Cut aerospace factory yesterday near Rockford, IL, and spoke with the management team. Our detailed thoughts are included inside....
Key Points Destocking largely complete with demand normalizing and lean inventories driving a restocking-led upturn Supply curtailments, China cost pressure, and policy tailwinds are reinforcing pricing power and margin recovery ......
Key Points We’re maintaining our Overweight rating on shares of AVAV and we’re updating our forecast post the firm’s 3QFY26 earnings report earlier this week. Our target price declines USD60 ......
Key Points We attended Howmet’s investor conference at its White Hall, MI facility yesterday and came away impressed with the management team’s focus on investments, execution and the growth outlook. ......
Key Points Disruptions lifting ethylene/PE, methanol, and fertilizer prices should also benefit downstream chains like chlorovinyls and acetyls Higher oil prices and a wider U.S. feedstock advantage suggest estimates for ......
Key Points Cost cuts, reliability gains, and the PEM improvement plan drive earnings upside largely independent of demand recovery Shares continue to price in housing weakness, while demographic tailwinds and ......